Status:

COMPLETED

Resolution of Thrombi in Left Atrial Appendage With Edoxaban

Lead Sponsor:

Keimyung University Dongsan Medical Center

Collaborating Sponsors:

Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company

Conditions:

Atrial Fibrillation

Left Atrial Appendage Thrombosis

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

Non-valvular (NV) atrial fibrillation (AF) increases the risk of stroke by approximately fivefold. The atrial thrombi associated with AF are seen within the left atrial appendage (LAA) in most cases (...

Eligibility Criteria

Inclusion

  • Men or women aged ≥ 20 years
  • Hemodynamically stable nonvalvular AF or atrial flutter
  • LAA thrombus documented by TEE up to 72 hours prior to start of study medication
  • VKA or NOAC-naïve or untreated within 1 month prior to sign the informed consent
  • VKA pretreated but under the therapeutic International Normalized ratio levels (\<2.0; documented with at least 2 consecutive measurements that are at least 24 hours apart) within last 6 weeks
  • Women of childbearing potential and men must agree to use adequate contraception when sexually active

Exclusion

  • Transient Ischemic Attack within 3 days prior to study inclusion
  • Severe, disabling stroke (modified Rankin score of 4-5, inclusive) within 3 months or any stroke within 14 days before the start of study drug
  • Acute thromboembolic events or thrombosis (venous/arterial) within the last 14 days prior to study inclusion
  • Acute myocardial infarction within the last 14 days prior to study inclusion
  • Cardiac-related criteria: Previous intracardiac thrombus, Free-floating ball thrombus, Intracardiac tumor, known left ventricular or aortic thrombus
  • Active bleeding or high risk for bleeding contraindicating anticoagulant therapy

Key Trial Info

Start Date :

May 19 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2024

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT03840291

Start Date

May 19 2019

End Date

August 1 2024

Last Update

August 19 2024

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Keimyung University Dongsan Medical Center

Daegu, South Korea, 41931

2

Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital

Daegu, South Korea, 41944

3

Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital

Daegu, South Korea, 42415

4

Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center

Daegu, South Korea, 42472

Resolution of Thrombi in Left Atrial Appendage With Edoxaban | DecenTrialz